Neuroimmune coupling via sensory pathways further reinforces myeloid predominance and T-cell dysfunction in bone tumors, suggesting that neurotrophin gradients contribute to immune exclusion and impaired effector quality (84–86). Here, BDNF is linked to bone neoplasm.